glp-1/gip/glucagon triple agonist Courtesy ref no. 43-Schematic demonstrating the working principle, Frontiers | Clinical perspectives on
Description
"Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes"
doi: 10.1136/bmj.d6898 13 MonamiMCandidoRPintaudiBTargherGMannucciEof the SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes
2019;7(1) doi: 10.1136/bmjdrc-2019-000728
[DOI] [PubMed] [Google Scholar] 100.Rosenstock J, Wysham C, Fras JP, et al
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: Preclinical biology and mechanisms of action
2023, doi: 10.1007/s12630-023-02549-5
